Chapter 24: Problem 13
Distinguish between oncogenes and proto-oncogenes. In what ways can proto- oncogenes be converted to oncogenes?
Short Answer
Expert verified
Answer: Oncogenes are altered forms of proto-oncogenes that contribute to the initiation or progression of cancer by causing uncontrolled cell growth. In contrast, proto-oncogenes are normal genes involved in cell growth, differentiation, and division, and they play a critical role in maintaining a balance between cell growth and cell death. Proto-oncogenes can be converted into oncogenes through genetic alterations such as mutations, gene amplification, chromosomal translocation, and viral integration.
Step by step solution
01
Define Oncogenes and Proto-oncogenes
Oncogenes are altered forms of normal cellular genes (proto-oncogenes) that, when activated, contribute to the initiation or progression of cancer. Proto-oncogenes are normal genes that play a crucial role in cell growth, differentiation, and division. To better understand the distinction between oncogenes and proto-oncogenes, we must dive into the roles and functions of these genes in living organisms.
02
Differentiate between Oncogenes and Proto-oncogenes
Oncogenes and proto-oncogenes differ in their roles and effects on cellular processes:
• Oncogenes result in the uncontrolled growth of cells, which can contribute to the formation and growth of cancer. They usually promote cell growth and survival, making it difficult for the body to eliminate these cells.
• Proto-oncogenes, on the other hand, are essential for normal cell growth and development. They are involved in functions such as cell division, apoptosis (programmed cell death), and DNA repair. When functioning correctly, they maintain a proper balance between cell growth and cell death.
In summary, proto-oncogenes have essential roles in controlling cell growth and differentiation, while oncogenes can cause uncontrolled cell growth, which can lead to cancer.
03
Explain the Conversion from Proto-oncogenes to Oncogenes
Proto-oncogenes can be converted to oncogenes through various genetic alterations, such as:
1. Mutation within the proto-oncogene or its regulatory region: A point mutation, deletion, or insertion in the genetic sequence can cause a change in the gene's function, leading to the uncontrolled growth of cancer cells.
2. Gene amplification: An increase in the number of copies of the proto-oncogene can lead to excessive production of the gene's protein product, resulting in over-stimulation of cell growth and division.
3. Chromosomal translocation: A genetic change where a part of one chromosome is transferred to another chromosome. If this translocation places the proto-oncogene adjacent to a highly active gene, it can result in increased expression of the proto-oncogene, leading to the formation of an oncogene.
4. Viral integration: Certain viruses can insert their DNA into the host's genome, leading to mutations or overexpression of the proto-oncogene, causing it to become an oncogene.
In conclusion, oncogenes are altered forms of proto-oncogenes that can lead to uncontrolled cell growth and cancer. Proto-oncogenes can be converted to oncogenes through various genetic alterations such as mutations, gene amplification, chromosomal translocation, and viral integration.
Unlock Step-by-Step Solutions & Ace Your Exams!
-
Full Textbook Solutions
Get detailed explanations and key concepts
-
Unlimited Al creation
Al flashcards, explanations, exams and more...
-
Ads-free access
To over 500 millions flashcards
-
Money-back guarantee
We refund you if you fail your exam.
Over 30 million students worldwide already upgrade their learning with Vaia!
Key Concepts
These are the key concepts you need to understand to accurately answer the question.
Genetic Mutations
Genetic mutations are permanent alterations in the DNA sequence that makes up a gene. These changes can result from errors during DNA replication or due to environmental factors such as radiation and chemical exposure. Mutations range from a single nucleotide change, known as a point mutation, to larger segments of the genome being affected. Not all mutations are harmful; some are neutral, and a few can even be beneficial. However, in the case of cancer, mutations can activate certain genes, such as proto-oncogenes, leading to cancerous growth.
There are two primary ways in which genetic mutations can occur:
There are two primary ways in which genetic mutations can occur:
- Germline mutations: These are inherited from a parent and are present in the reproductive cells, which means they can be passed on to offspring.
- Somatic mutations: These occur in individual cells after conception and accumulate over time. They affect all cells derived from the mutated cell but are not passed on to offspring.
Cancer Genetics
Cancer genetics focuses on the role that genetic mutations play in the initiation and development of cancer. Cells become cancerous when mutations disrupt the normal regulations governing cell growth and death, resulting in uncontrolled proliferation. The study of cancer genetics involves understanding how certain mutations can convert proto-oncogenes into oncogenes, which then drive the malignant transformation of cells.
Key factors that impact cancer genetics include:
Key factors that impact cancer genetics include:
- Genetic predisposition: Some individuals inherit mutations that increase their risk of developing cancer.
- Acquired mutations: Many mutations occur during an individual's lifetime due to various factors such as UV exposure, tobacco smoke, or other carcinogens.
- Oncogenes and tumor suppressor genes: The balance between these two types of genes is crucial for maintaining normal cell function. Oncogenes, when mutated, promote cancerous growth, while tumor suppressor genes work to inhibit it. Disruption in either can lead to cancer.
Cell Growth and Division
Cell growth and division are fundamental processes that occur in all living organisms. Normal cells undergo a regulated process known as the cell cycle, which consists of phases that prepare the cell for division and ensure that the genetic material is accurately replicated and distributed to the daughter cells. This precise control of cell growth, division, and programmed cell death (apoptosis) is crucial for maintaining healthy tissue function.
The critical stages of the cell cycle include:
Proto-oncogenes play key roles in regulating the cell cycle by producing proteins that signal cells to proceed with growth and division. However, if proto-oncogenes become oncogenes through mutation, they can push the cell cycle out of balance, leading to excessive division and the potential for cancer development.
The critical stages of the cell cycle include:
- Interphase: The cell prepares for division by replicating its DNA and producing necessary proteins.
- Mitosis: The cell divides its replicated DNA between two daughter cells.
- Cytokinesis: The cytoplasm divides, and two separate cells are formed.
Proto-oncogenes play key roles in regulating the cell cycle by producing proteins that signal cells to proceed with growth and division. However, if proto-oncogenes become oncogenes through mutation, they can push the cell cycle out of balance, leading to excessive division and the potential for cancer development.
Chromosomal Translocation
Chromosomal translocation is a genetic anomaly where a segment of one chromosome breaks off and reattaches to a different chromosome. This type of genetic modification can disrupt the normal function of genes and lead to diseases, including cancer. In the context of oncogenes, translocation may place a proto-oncogene next to a highly active gene, causing the proto-oncogene to be overexpressed.
An example of the consequences of chromosomal translocations include:
Diagnosing such translocations can be critical for determining an appropriate treatment plan. For example, patients with the Philadelphia chromosome may receive targeted therapies that specifically inhibit the activity of the fusion protein produced by the translocated genes.
An example of the consequences of chromosomal translocations include:
- Philadelphia chromosome: A well-known translocation between chromosomes 9 and 22, leading to the formation of a new fusion gene implicated in chronic myelogenous leukemia.
Diagnosing such translocations can be critical for determining an appropriate treatment plan. For example, patients with the Philadelphia chromosome may receive targeted therapies that specifically inhibit the activity of the fusion protein produced by the translocated genes.